Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Stummer

Showing results (331-340 of 342) with videos related to

Pageof 35
Sort By:
Journal of Neurosurgery. Spine|June 26, 2026
Oncological and neurological outcomes after parent rootlet resection in functionally critical spinal schwannomas: a retrospective multicenter comparative studyJuan Carlos Galeano Zapata, Emanuele Maragno, Marco Gallus, et al.
Journal of Biomedical Optics|May 16, 2023
Intraoperative molecular imaging: 3rd biennial clinical trials updatePatrick Bou-Samra, Najib Muhammad, Austin Chang, et al.
The Lancet. Oncology|December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastomaEnrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS TrialUlrich Herrlinger, Niklas Schäfer, Joachim P Steinbach, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Nature Biomedical Engineering|July 10, 2024
Localization of protoporphyrin IX during glioma-resection surgery via paired stimulated Raman histology and fluorescence microscopyMustafa Nasir-Moin, Lisa Irina Wadiura, Vlad Sacalean, et al.
Lancet (London, England)|February 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialUlrich Herrlinger, Theophilos Tzaridis, Frederic Mack, et al.
Advances in Experimental Medicine and Biology|November 10, 2024
Declaration of Computational NeurosurgeryAntonio Di Ieva, Eric Suero Molina, Margaret A Somerville, et al.
Journal of Neuro-Oncology|February 9, 2026
Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patientsChristian Mirian, Lasse Rehné Jensen, Adam Gorm Hoffmann, et al.
BMC Cancer|February 20, 2025
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastomaMatthias Schneider, Anna-Laura Potthoff, Yahya Ahmadipour, et al.
Pageof 35

Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
Journal of Neurosurgery. Spine|June 26, 2026
Oncological and neurological outcomes after parent rootlet resection in functionally critical spinal schwannomas: a retrospective multicenter comparative studyJuan Carlos Galeano Zapata, Emanuele Maragno, Marco Gallus, et al.
Journal of Biomedical Optics|May 16, 2023
Intraoperative molecular imaging: 3rd biennial clinical trials updatePatrick Bou-Samra, Najib Muhammad, Austin Chang, et al.
The Lancet. Oncology|December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastomaEnrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS TrialUlrich Herrlinger, Niklas Schäfer, Joachim P Steinbach, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Nature Biomedical Engineering|July 10, 2024
Localization of protoporphyrin IX during glioma-resection surgery via paired stimulated Raman histology and fluorescence microscopyMustafa Nasir-Moin, Lisa Irina Wadiura, Vlad Sacalean, et al.
Lancet (London, England)|February 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialUlrich Herrlinger, Theophilos Tzaridis, Frederic Mack, et al.
Advances in Experimental Medicine and Biology|November 10, 2024
Declaration of Computational NeurosurgeryAntonio Di Ieva, Eric Suero Molina, Margaret A Somerville, et al.
Journal of Neuro-Oncology|February 9, 2026
Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patientsChristian Mirian, Lasse Rehné Jensen, Adam Gorm Hoffmann, et al.
BMC Cancer|February 20, 2025
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastomaMatthias Schneider, Anna-Laura Potthoff, Yahya Ahmadipour, et al.
Pageof 35